Analysts are estimating that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.04. Anticipation surrounds Lineage Cell Therapeutics's announcement, with investors hoping to hear ...
A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.
The Western medical establishment ousted him. China embraced him. Will the man on a mission to perform the first human head transplant ever pull it off?
Third Quarter Revenue Growth of 12%Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 MillionRepresenting Growth of 27% to 31% Xtant Medical ...
Third Quarter Revenue Growth of 12%Reaffirms Full Year 2024 Revenue Guidance of $116 Million to $120 MillionRepresenting Growth of 27% to 31% BELGRADE, MT / ACCESSWIRE / November 12, 2024 / Xtant ...